Tryp Therapeutics Stock Shares Owned By Insiders
TRYPFDelisted Stock | USD 0.05 0 6.89% |
Tryp Therapeutics fundamentals help investors to digest information that contributes to Tryp Therapeutics' financial success or failures. It also enables traders to predict the movement of Tryp OTC Stock. The fundamental analysis module provides a way to measure Tryp Therapeutics' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Tryp Therapeutics otc stock.
Tryp |
Tryp Therapeutics OTC Stock Shares Owned By Insiders Analysis
Tryp Therapeutics' Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.
More About Shares Owned By Insiders | All Equity Analysis
Insiders Shares | = | Executives Shares | + | Employees |
Current Tryp Therapeutics Shares Owned By Insiders | 47.24 % |
Most of Tryp Therapeutics' fundamental indicators, such as Shares Owned By Insiders, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Tryp Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Although the research on effects of insider trading on prices and volatility is still relatively inconclusive, and investors are advised to pay close attention to the distribution of equities among company's stakeholders to avoid many problems associated with the disclosure of price-sensitive information.
CompetitionBased on the latest financial disclosure, 47.24% of Tryp Therapeutics are shares owned by insiders. This is 211.2% higher than that of the Healthcare sector and 233.15% higher than that of the Biotechnology industry. The shares owned by insiders for all United States stocks is notably lower than that of the firm.
Tryp Shares Owned By Insiders Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Tryp Therapeutics' direct or indirect competition against its Shares Owned By Insiders to detect undervalued stocks with similar characteristics or determine the otc stocks which would be a good addition to a portfolio. Peer analysis of Tryp Therapeutics could also be used in its relative valuation, which is a method of valuing Tryp Therapeutics by comparing valuation metrics of similar companies.Tryp Therapeutics is currently under evaluation in shares owned by insiders category among its peers.
Tryp Fundamentals
Return On Equity | -9.22 | |||
Return On Asset | -2.05 | |||
Current Valuation | 4.17 M | |||
Shares Outstanding | 96.42 M | |||
Shares Owned By Insiders | 47.24 % | |||
Shares Owned By Institutions | 0.04 % | |||
Price To Book | 2.50 X | |||
EBITDA | (7.36 M) | |||
Net Income | (7.49 M) | |||
Cash And Equivalents | 2.85 M | |||
Cash Per Share | 0.03 X | |||
Current Ratio | 6.14 X | |||
Book Value Per Share | (0) X | |||
Cash Flow From Operations | (5.81 M) | |||
Earnings Per Share | (0.13) X | |||
Beta | -1.29 | |||
Market Capitalization | 6.56 M | |||
Total Asset | 2.34 M | |||
Z Score | -9.9 | |||
Net Asset | 2.34 M |
About Tryp Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Tryp Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tryp Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tryp Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in american community survey. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Consideration for investing in Tryp OTC Stock
If you are still planning to invest in Tryp Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Tryp Therapeutics' history and understand the potential risks before investing.
FinTech Suite Use AI to screen and filter profitable investment opportunities | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. |